Derivative and derivative ratio spectrophotometric analysis of antihypertensive ternary mixture of amiloride hydrochloride, hydrochlorothiazide and timolol maleate

Journal of the Chinese Chemical Society

Volumn 55, Issue 5, 2008, Pages 971-978

  Abdel Hay, Mohamed H ^a   Gazy, Azza A ^a   Hassan, Ekram M ^a   Belal, Tarek S ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Amiloride hydrochloride; Derivative ratio spectrophotometry; Derivative spectrophotometry; Hydrochlorothiazide; Timolol maleate

Indexed keywords

EID: 56849088754     PISSN: 00094536     EISSN: None     Source Type: Journal    
DOI: 10.1002/jccs.200800144     Document Type: Article

References (28)

1. O'Haver, T.-C.; Green, G.-L. Anal. Chem. 1976, 48(2), 312.
2. O'Haver, T.-C. Anal. Chem. 1979, 51, 91A.
3. Morelli, B. Talanta 1994, 41(4), 479.
4. Morelli, B. Fresenius J. Anal. Chem. 1996, 354, 97.
5. Salinas, F.; Berzas Nevado, J.-J.; Espinosa Mansilla, A. Talanta 1990, 37(3), 347.
6. Berzas Nevado, J.-J.; Guiberteau Cabanillas, C.; Salinas, F. Talanta 1992, 39(5), 547.
7. El-Yazbi, F.-A.; Kovar, K.-A. Sci. Pharm. 1998, 66, 325.
8. El-Yazbi, F.-A.; Abdine, H.-H.; Shaalan, R.-A.; Korany, E.-A. Spectrosc. Lett. 1998, 31(7), 1403.
9. Morelli, B. Anal. Lett. 1994, 27(14), 2751.
10. Morelli, B. J. Pharm. Biomed. Anal. 1995, 13(3), 219.
11. th ed.; The Pharmaceutical Press: London, 2005.
12. The British Pharmacopoeia. Her Majesty's Stationery Office: London, 2003.
13. rd ed.; United States Pharmacopoeial Convention, Inc.: Washington, D.C., 2005.
14. Maguregui, M.-I.; Jiménez, R.-M.; Alonso, R.-M. J. Chromatogr. Sci. 1998, 36(10), 516.
15. Erk, N.; Onur, F. Anal. Lett. 1997, 30(8), 1503.
16. Prasad, C.-V.-N.; Parihar, C.; Sunil, K.; Parimoo, P. J. Pharm. Biomed. Anal. 1998, 17(4-5), 877.
17. Martin, M.-E.; Hernandez, M.-E.; Jimenez, A.-I.; Arias, J.-J.; Jimenez, F. Anal. Chim. Acta 1999, 381(2-3), 247.
18. Kartal, M.; Erk, N. J. Pharm. Biomed. Anal. 1999, 19(3-4), 477.
19. Zecevic, M.; Zivanovic, L.-J.; Agatonovic-Kustrin, S.; Ivanovic, D.; Maksimovic, M. J. Pharm. Biomed. Anal. 2000, 22(1), 1.
20. Zecevic, M.; Zivanovic, L.; Agatonovic-Kustrin, S.; Minic, D. J. Pharm. Biomed. Anal. 2001, 24(5-6), 1019.
21. Bigley, F.-P.; Grob, R.-L.; Brenner, G.-S. Anal. Chim. Acta 1986, 181, 241.
22. Zhu, D. Yaowu Fenxi Zazhi 1987, 7(2), 83.
23. Hassan, E.-M.; Gazy, A.-A.; Abdel-Hay, M.-H.; Belal, T.-S. Bull. Fac. Pharm. Cairo Univ. 2006, 44(2), 185.
24. Ferraro, M.-C.-F.; Castellano, P.-M.; Kaufman, T.-S. J. Pharm. Biomed. Anal. 2004, 34(2), 305.
25. th ed.; Muller, N.-F.; Dessing, R.-P., Eds.; European Society of Clinical Pharmacy: Deutscher Apotheker Verlag Stuttgart, 1997; p 826.
26. Medicines Compendium; Datapharm Communications Ltd: London, 2002; p 1290.
27. Guidance for Industry; Q2B Validation of Analytical Procedures: Methodology; International Conference on Harmonization (ICH), November 1996, please visit at http://www.fda.gov/eder/guidance/1320fnl.pdf.
28. th ed.; Prentice Hall: Harlow, 2000; pp 57-64, 77-78, 184-187.